CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the universal balloon design of the HeartLight Endoscopic Ablation System and introduces an advanced feature set that optimizes the speed and magnitude of target tissue contact during pulmonary vein isolation (PVI) procedures.
Edwards Lifesciences Corp. announced that it has closed its acquisition of Valtech Cardio Ltd., developer of the Cardioband System for transcatheter repair of the mitral and tricuspid valves. Edwards announced in November that it had signed an agreement to acquire Valtech.
Survival statistics, surgeon-specific experience and complication rates are the types of information most wanted by parents of children with congenital heart disease, according to a survey released at the 53rd Annual Meeting of The Society of Thoracic Surgeons (STS).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Elderly patients with aortic stenosis (AS) and medium surgical risk experienced better than expected results after undergoing traditional surgical aortic valve replacement (SAVR), according to research presented at the 53rd Annual Meeting of The Society of Thoracic Surgeons.
Using data from a national study, Johns Hopkins researchers determined that using heart computed tomography (CT) scans can help personalize treatment in patients whose blood pressure falls in the gray zone of just above normal or mild high blood pressure. Previously, the appropriate blood pressure treatment for these patients used risk calculations and some guesswork, potentially leaving many vulnerable to heart disease or taking drugs they do not need. Nearly one in three adults in the United States has prehypertension, blood pressure higher than normal but not considered high yet.
January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Carestream Health will demonstrate a zero-footprint enterprise imaging platform that can easily enable new use cases and modules at the upcoming Healthcare Information and Management Systems Society (HIMSS) conference, Feb. 19-23 in Orlando, Fla.
Stereotaxis Inc. announced the release of an interface between its remote magnetic navigation system for electrophysiology (EP) procedures and the Philips Allura Xper FD10 cardiovascular X-ray system. The interface allows interoperability of the Stereotaxis Niobe system with the Philips Allura Xper FD10 version R8.2 system and is available worldwide.
Biotronik has enrolled the first patients in the BioInsight clinical study evaluating the safety and feasibility of performing the minimally invasive BioMonitor 2 insertion procedure in an office setting.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 20, 2017 — A new document from the European Association of Cardiovascular Imaging (EACVI) and the American ...
January 19, 2017 — Apollo Enterprise Imaging Corp. announced it has entered into an agreement with DiACardio Ltd to ...
Intelerad Medical Systems announced a partnership with Laurel Bridge Software that will allow Intelerad to offer a number of solutions that address complex data, networking and architectural challenges common in multi-facility, cross-enterprise organizations.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Zetta Medical Technologies announced the release of Zia, an iterative reconstruction solution that enables the use of low-dose computed tomography (CT) protocols for CT scanners.
Materialise NV has launched AnatomyPrint, an easy-to-use service for medical professionals that delivers 3-D printed anatomical models directly to their doorsteps. The new service was launched during the 2016 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting, Nov. 27-Dec. 2 in Chicago.
A new study published in Circulation has found there is a 23 percent risk in reduction of all-cause mortality in non-ischemic cardiomyopathy patients with use of implantable cardioverter-defibrillator (ICD) therapy.